; and (B) opportunities for preventative and diagnostic measures for such a disease, including the study of molecular pathology and biomarkers for early detection of such disease. (2) Experimental treatment and prevention In the case of an entity that is a hospital or a health care facility, the Secretary may award a grant or enter into a cooperative agreement with such an entity for the purpose of supporting an experimental treatment or prevention program for liver cancer carried out by such entity. (3) Authorization of appropriations For purposes of carrying out this subsection, there is authorized to be appropriated $45,000,000 for each of fiscal years 2019 through 2023. Any amounts appropriated under this paragraph shall remain available until expended. . 4. Liver cancer and disease prevention and awareness grants Subpart I of part D of title III of the Public Health Service Act ( 42 U.S.C. 254b et seq.) is amended by adding at the end the following new section: 330N. Liver cancer and disease prevention and awareness grants (a) Prevention initiative grant program (1) In general The Secretary, through the Director of the Centers for Disease Control and Prevention, may award grants and enter into cooperative agreements with entities for the purpose of expanding and supporting— (A) prevention activities (including providing screenings, vaccinations, or other preventative treatment) for conditions known to increase an individual’s risk of developing a major liver disease, such as liver cancer, hepatitis B, hepatitis C, nonalcoholic fatty liver disease, and cirrhosis of the liver